About us

More than 10 years of expertise in providing tailor-made solutions for the market access of pharmaceutical products, medical devices, and digital health applications.

Early Benefit Assessment and AMNOG Price Negotiations

Full-scale AMNOG support: strategy, dossier, price negotiation, and arbitration. 

European Health Technology Assessment

Strategic advice and EU dossiers in collaboration with our European partner network.

Digital Health Applications (DiGA)

Advice on how to make your medical app reimbursable.

Loss of Exclusivity

Optimization of product sales after expiry of patent and data exclusivity.

Statistics for Market Access

Customized statistical evaluation of clinical trials for all questions regarding market access.